Osteoprotegerin antibody and its neighbours: when a target breaks the default protocol

What each target demands

1. Osteoprotegerin: a secreted decoy receptor, usually measured in fluid. It circulates and binds its ligand, so the honest measurement is usually an immunoassay on serum or conditioned medium rather than a tissue stain. A matched standard and a matrix-matched control are what make the number mean anything, and a western blot of tissue lysate answers a different question.
2. Decorin: a proteoglycan that will not run as a band. The core protein carries a glycosaminoglycan chain that makes it migrate as a broad smear at a much higher apparent mass than the sequence predicts. Enzymatic removal of the chain before electrophoresis converts the smear into a band, and an antibody raised against the core protein may need that treatment to see anything at all.
3. CD36: a membrane scavenger receptor with conformational epitopes. Many antibodies against it recognise the folded extracellular domain, so reducing and boiling the sample can abolish the signal. Test non-reducing conditions and a gentler denaturation before concluding the antibody does not work, and check whether the clone was raised for flow cytometry rather than for blotting.
4. Match the antibody to the application, not to the target. For all three, an antibody sold for flow cytometry, one for immunohistochemistry and one for immunoassay capture are frequently different clones with different evidence. Buy against the application you will run and read the evidence for that application specifically.
5. Run the sample-type control, not just the reagent control. For a secreted target, a depleted or blank matrix. For a proteoglycan, a deglycosylated and an untreated lane side by side. For a surface receptor, a cell line known not to express it. These are the controls that actually interpret the result.

Immunoassay against stain, for a secreted target

Immunoassay gives a number with a standard curve and needs a matched pair of antibodies, one to capture and one to detect, against different epitopes. A stain gives a location and cannot be quantified beyond a coarse score without considerable care.

If both are needed, buy them as a pair from a supplier who has shown they work together. Assembling a sandwich assay from two antibodies chosen independently is a longer project than it looks.

Species reactivity and why it disappoints

Secreted and matrix proteins are often less conserved in their exposed regions than their names suggest, so an antibody validated in one species may be weak in another. Read the species claim to see whether it was tested or predicted from sequence.

Where a model organism matters, ask for the data in that species specifically. Predicted reactivity is a hypothesis, and it is your experiment that tests it.

Buying the pair and keeping it working

Immunoassay reagents are the ones most damaged by lot change, because a small shift in either antibody moves the whole standard curve. Bank a single lot of each for the study and bridge lots with an overlap run before switching.

Keep the standard's own lot and source recorded with the data. Comparing values between studies that used different standards is the commonest way an immunoassay result stops being comparable.

An IGFBP2 antibody or IGFBP3 antibody reports a binding protein, not the hormone

A substantial part of this category is antibodies against carrier and binding proteins rather than the signalling molecules themselves. They report availability rather than free concentration, and their levels move with nutritional state, inflammation and liver function independently of the hormone they carry.

That makes them useful and easy to over-read. State what was measured, and measure the partner where the claim concerns signalling. The difference between an informative result and one that will be questioned is usually a sentence in the methods rather than a better reagent.

KIM-1 antibody targets: injury markers are state markers

Several widely used markers are not cell identifiers at all: they are proteins that appear on a cell type only when it is injured, activated or transformed. Read as a lineage marker they produce nonsense; read as a state marker they are among the most informative reagents available.

For a marker of injury, the control is a tissue or a sample from an uninjured subject processed in the same run, and the time course matters, because these proteins appear and clear on their own schedule rather than the experiment's.

Pre-analytical handling of a fluid sample

Proteins measured in blood or urine are affected by the tube, the time to processing, the temperature and the number of freeze and thaw cycles, and some are actively degraded by enzymes released during collection. A difference between two cohorts collected under different protocols is a collection difference until proven otherwise.

Write the collection protocol into the study design, keep it identical between arms, and record the deviations. No antibody, however good, recovers a protein that was destroyed before the assay started.

An htra1 antibody and a secreted protease

HTRA1 is a secreted serine protease implicated in matrix turnover and in eye and vascular disease, so an htra1 antibody often reports conditioned medium as well as cells and the collection time belongs in the method. It autoprocesses, so several bands are expected, and the family shares a domain which makes specificity data worth reading before a tissue claim.

An anti-lysyl oxidase reagent and the family behind it

An anti-lysyl oxidase antibody may target the founding enzyme or one of the like proteins, which are different genes with different roles in crosslinking, so the listing has to name it. The enzyme is secreted and processed, so the proenzyme and mature forms differ in mass, and activity is measured with a substrate assay rather than inferred from the band.

A galc antibody and a lysosomal enzyme

Galactosylceramidase is the enzyme lost in Krabbe disease, so a galc antibody is used to confirm absence or reduction and the negative control is patient derived material. It is a lysosomal glycoprotein processed into fragments, so the expected masses belong in the method, and enzyme activity in a fluorometric assay remains the diagnostic measurement rather than the blot.

Common questions

Why does my decorin antibody give a smear rather than a band?

Because the glycosaminoglycan chain on the core protein makes migration heterogeneous. Treating the sample to remove the chain before electrophoresis collapses the smear into a band at the predicted core mass.

Should osteoprotegerin be measured by western blot or immunoassay?

Usually immunoassay, because it is secreted and the question is normally how much is present in a fluid. A blot tells you about a lysate, which for a secreted protein is rarely the sample you care about.

Why did my cd36 antibody stop working after I changed the protocol?

Most likely you started reducing or boiling the sample, and the clone recognises a conformational epitope on the folded extracellular domain. Try non-reducing conditions and a lower denaturation temperature.

Can one antibody serve flow cytometry and western blotting?

Sometimes, and it has to be shown rather than assumed. A clone selected against native surface protein and one selected against a denatured fragment are answering different questions, and the datasheet should show evidence for each application separately.

Does a binding protein measurement tell me about the hormone?

Only indirectly. Binding proteins report carriage and availability, and their levels move with nutrition, inflammation and liver function on their own. Where the claim concerns signalling, measure the partner as well and say which was measured.

Browse by service class

• Compare Gene synthesis on advertised prices